AUA2022: Diagnosis And Management Of Localized, Locally Advanced And Advanced Kidney Cancer
AUAUniversity10 Aug 2022

AUA2022: Diagnosis And Management Of Localized, Locally Advanced And Advanced Kidney Cancer

Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer (2022) CME Available: https://auau.auanet.org/node/36089 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Differentiate among the subtypes of kidney cancer, with emphasis on clinical management decisions, and outline ways in which knowledge of kidney cancer subtypes can alter surgical approach. 2. Apply advanced strategies for partial nephrectomy for patients with endophytic, hilar and multiple tumors including role of warm ischemia, intraoperative ultrasound, techniques for hemostatic control, the role of off-clamp and selective hilar clamping, the use of the retroperitoneal approach and methods for renorrhaphy. 3. Employ techniques for management of large and/or locally advanced tumors including management of renal vein or inferior vena cava invasion and the use of lymphadenectomy. 4. Identify the role of cytoreductive nephrectomy and/or resection of metastatic foci in patients with advanced disease. 5. Identify new and emerging targeted therapy and immuno-oncology options for patients with locally advanced and advanced kidney cancer and the role of adjuvant therapy.

Avsnitt(426)

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide CME Available: https://auau.auanet.org/node/38322 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational g...

23 Aug 20231h 42min

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/38312 CME Expiration ...

16 Aug 20231h 59min

Treatment for Hormone Sensitive Prostate Cancer

Treatment for Hormone Sensitive Prostate Cancer

Treatment for Hormone Sensitive Prostate Cancer CME Available: https://auau.auanet.org/node/38703 Treatment for Hormone Sensitive Prostate Cancer (2023), is an exciting new educational offering to u...

9 Aug 202349min

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men Now in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, f...

2 Aug 202325min

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider CME Available: https://auau.auanet.org/node/38307 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent...

26 Juli 20231h 57min

AUA2023: Upper-Tract Urothelial Cancer Guidelines

AUA2023: Upper-Tract Urothelial Cancer Guidelines

AUA2023: Upper-Tract Urothelial Cancer Guidelines: An Interactive and Evidence-based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video Presentation CME Available: https:/...

19 Juli 20232h 2min

AUA2023: What the General Urologist Should Know about Care of Transgender Patients

AUA2023: What the General Urologist Should Know about Care of Transgender Patients

AUA2023: What the General Urologist Should Know about Care of Transgender Patients CME Available: https://auau.auanet.org/node/38342 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educa...

12 Juli 20231h 52min

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Indep...

5 Juli 20231h 54min

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
alska-oss
harrisons-dramatiska-historia
nu-blir-det-historia
sektledare
rss-viktmedicinpodden
johannes-hansen-podcast
not-fanny-anymore
roda-vita-rosen
i-vantan-pa-katastrofen
rss-sjalsligt-avkladd
allt-du-velat-veta
rss-basta-livet
rss-om-vi-ska-vara-arliga
sa-in-i-sjalen
rss-max-tant-med-max-villman
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-pa-insidan-med-bjorn-rudman